Association of variants of the done for mannose-binding lectin with susceptibility to meningococcal disease

Lancet

Volumn 353, Issue 9158, 1999, Pages 1049-1053

  Hibberd, Martin L ^a   Sumiya, Michiko ^a   Summerfield, John A ^a   Booy, Robert ^a,b   Levin, Michael ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MANNOSE BINDING PROTEIN; PROPERDIN; RESTRICTION ENDONUCLEASE; CARRIER PROTEIN; COLLECTIN; LECTIN;

ADOLESCENT; ARTICLE; BACTERIAL COLONIZATION; CHILD; COMPLEMENT ACTIVATION; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; HUMAN; INFANT; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; MALE; MENINGOCOCCOSIS; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; ADULT; AGED; ALLELE; CASE CONTROL STUDY; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENETICS; GENOTYPE; MIDDLE AGED; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE;

ADOLESCENT; ADULT; AGED; ALLELES; BASE SEQUENCE; CARRIER PROTEINS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; COLLECTINS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INFANT; LECTINS; MALE; MENINGOCOCCAL INFECTIONS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; VARIATION (GENETICS);

EID: 0033608862     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(98)08350-0     Document Type: Article

References (33)

1. Cartwright K. Meningococcal carriage and disease. In: meningococcal disease. Chichester: John Wiley, 1995: 159-77.
2. Caugant D.A., Hoiby E.A., Magnus P.et al. Asymptomatic carriage of Neisseria meningitidis in a randomly sampled population. J Clin Microbiol. 32:1994;323-330.
3. Nadel S., Levin M., Habibi P. Treatment of meningococcal disease in childhood. Cartwright K. Meningococcal disease. 1995;207-243 John Wiley, Chichester.
4. Caugant D.A., Froholm L.O., Bovre K.et al. Intercontinental spread of a genetically distinctive complex of clones of Neisseria meningitidis causing epidemic disease. Proc Natl Acad Sci USA. 83:1986;4927-4931.
5. Goldschneider I., Gotschlich E.C., Artenstein M.S. Human immunity to the meningococcus II: development of natural immunity. J Exp Med. 129:1969;1327-1348.
6. Gotschlich E.C., Goldschneider I., Artenstein M.S. Human immunity to the meningococcus V: the effect of immunization with meningococcal group C polysaccharide on the carrier state. J Exp Med. 129:1969;1385-1396.
7. Fearon D.T. Seeking wisdom in innate immunity. Nature. 388:1997;323-324.
8. Fearon D.T., Locksley R.M. The instructive role of innate immunity in the acquired immune response. Science. 272:1996;50-53.
9. Ross S.C., Densen P. Complement deficiency states and infection: epidemiology, pathogenesis and consequences of neisserial and other infections in an immune deficiency. Medicine. 63:1984;243-273.
10. Figueroa J.E., Densen P. Infectious diseases associated with complement deficiencies. Clin Microbiol Rev. 4:1991;359-395.
11. Fijen C.A., Kuijper E.J., Hannema A.J., Sjoholm A.G., van-Putten J.P. Complement deficiencies in patients over ten years old with meningcoccal disease due to uncommon serogroups. Lancet. ii:1989;585-588.
12. Densen P., Weiler J.M., Griffiss M., Hoffmann L.G. Familial properdin deficiency and fatal meningoccaemia: correction of the bactericidal defect by vaccination. N Engl J Med. 316:1987;922-926.
13. Thiel S.S., Vorup-Jensen T., Stover C.M.et al. A second serine protease association with mannan-binding lectin that activates complement. Nature. 386:1997;506-510.
14. Tan S.M., Chung M.C.M., Kon O.L., Thiel S., Lee S.H., Lu J. Improvements on the purification of mannan-binding lectin and demonstration of its Ca2+ independent association with a C1s-like serine protease. Biochem J. 319:1996;329-332.
15. Ohta M., Okada M., Yamashina I., Kawasaki T. The mechanism of carbohydrate-mediated complement activation by the serum mannan-binding protein. J Biol Chem. 265:1990;1980-1984.
16. Turner M.W. Mannose-binding lectin: the pluripotent molecule of the innate immune system. Immunol Today. 11:1996;532-540.
17. Tabona P., Mellor A., Summerfield J.A. Mannose binding protein is involved in first-line host defence: evidence from transgenic mice. Immunology. 85:1995;153-159.
18. Madsen H.O., Garred P., Kurtzhals J.A.L.et al. A new frequent allele is the missing link in the structural polymorphism of the human mannan-binding protein. Immunogenetics. 40:1994;37-40.
19. Sumiya M., Super M., Tabona P.et al. Molecular basis of opsonic defect in immunodeficient children. Lancet. 337:1991;1569-1570.
20. Lipscombe R.J., Sumiya M., Hill A.V.S.et al. High frequencies in African and non-African populations of independent mutations in the mannose binding protein gene. Hum Mol Genet. 1:1992;709.
21. Lipscombe R.J., Sumiya M., Summerfield J.A., Turner M.W. Distinct physico-chemical characteristics of human binding protein (MBP) expressed by individuals of differing genotype. Immunology. 85:1995;660-667.
22. Super M., Thiel S., Lu J., Levinsky R.J., Turner M.W. Association of low levels of mannan-binding protein with a common defect of opsonisation. Lancet. ii:1989;1236-1239.
23. Garred P., Madsen H.O., Hoffmann B., Svejgaard A. Increased frequency of homozygosity of abnormal mannan-binding-protein alleles in patients with suspected immunodeficiency. Lancet. 346:1995;941-943.
24. Summerfield J.A., Sumiya M., Levin M., Turner M.W. Association of mutations in mannose binding protein gene with childhood infection in consecutive hospital series. BMJ. 314:1997;1229-1232.
25. Summerfield J.A., Ryder S., Sumiya M.et al. Mannose binding protein gene mutations associated with unusual and severe infections in adults. Lancet. 345:1995;886-889.
26. Marsden H.O., Garred P., Thiel S.et al. Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein. J Immunol. 155:1995;3013-3020.
27. Mead R., Jack D., Pembrey M., Tyfield L., Turner M. Mannose-binding lectin alleles in a prospectively recruited UK population: the ALSPAC Study Team. Lancet. 349:1997;1669-1670.
28. Pollack M.M., Kantilal M.P., Ruttimann U.E. PRISM III: an updated pediatric risk of mortality score. Crit Care Med. 24:1996;743-752.
29. Miettinen O.S. Proportion of disease caused or prevented by a given exposure, trait or intervantion. Am J Epidemiol. 99:1974;325-332.
30. Garred P., Madsen H.O., Kurtzhals J.A.et al. Diallelic polymorphism may explain variations of the blood concentrations of mannan-binding protein in Eskimos, but not in black Africans. Eur J Immunogenet. 19:1992;403-412.
31. Hammerschmidt S., Hilse R., van Puuen J.P., Gerardy-Schahn R., Unkmeir A., Frosch M. Modulation of cell surface sialic acid expression in Neisseria meningitidis via a transportable genetic element. EMBO J. 15:1996;192-198.
32. de Vries F.P., van Der Ende A., van Putten J.P., Dankert K. Invasion of primary nasopharyngeal epithelial cells by Neisseria meningitidis is controlled by phase variation of multiple surface antigens. Infect Immun. 64:1996;2998-3006.
33. Jack D.L., Dodds A.W., Anwar N.et al. Activation of complement by mannose-binding lectin in isogenic mutants of Neisseria meningitidis serogroup B. J Immunol. 160:1998;1346-1353.